Skip to main content
    Z

    Zoetis Inc (ZTS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $84.42
    +0.61 (+0.72%)

    Market Cap: $34.06B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zoetis Inc (ZTS) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Zoetis (ZTS) is expected to report earnings on Feb 10, 2027. In the quarter ended Sep 30, 2026, Zoetis reported EPS of $1.75, above the $1.51 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    83%(33/40)
    Avg Surprise
    +6.74%
    Streak
    2 Q

    Upcoming Estimates

    Reports Feb 10, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.20
    Range$1.12 - $1.35
    15 analysts
    Revenue Consensus
    $2.20B
    Range$2.10B - $2.35B
    13 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$1.50
    Range$1.41 - $1.57
    9 analysts
    EPS Revisions
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$1.57-4.8%
    60d ago$1.52-1.5%
    30d ago$1.52-1.5%
    7d ago$1.50+0.2%
    Current$1.50
    Revenue Consensus
    $2.24B
    Range$2.18B - $2.29B
    7 analysts

    Next Report

    ZTS has an expected report date of Feb 10, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 18.9% below the $1.48 reported for the quarter ended Dec 31, 2025.

    ZTS Earnings Call

    The latest ZTS earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, ZTS beat 33, missed 4 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $2.39B, down 1.2% from $2.42B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.75$1.51$1.44 - $1.61+15.89%Beat+2.9%130 up, 13 downNov 5, 2026$2.39B
    Jun 30, 2026$1.87$1.84$1.77 - $1.90+1.63%Beat+6.3%140 up, 1 downAug 6, 2026$2.47B
    Mar 31, 2026$1.53$1.62$1.56 - $1.65-5.56%Miss+3.4%150 up, 6 downMay 7, 2026$2.26B
    Dec 31, 2025$1.48$1.40$1.38 - $1.43+5.71%Beat+5.7%162 up, 0 downFeb 12, 2026$2.39B
    Sep 30, 2025$1.70$1.62$1.59 - $1.65+4.94%Beat+7.6%121 up, 5 downNov 4, 2025$2.42B
    Jun 30, 2025$1.76$1.61$1.57 - $1.66+9.32%Beat+12.8%124 up, 0 downAug 5, 2025$2.47B
    Mar 31, 2025$1.48$1.40$1.34 - $1.47+5.71%Beat+7.2%130 up, 4 downMay 6, 2025$2.20B
    Dec 31, 2024$1.40$1.36$1.05 - $1.42+2.94%Beat+12.9%131 up, 4 downFeb 13, 2025$2.32B
    Sep 30, 2024$1.58$1.46$1.42 - $1.50+8.22%Beat+16.2%110 up, 0 downNov 4, 2024$2.39B
    Jun 30, 2024$1.56$1.48$1.46 - $1.53+5.41%Beat+10.6%110 up, 0 downAug 6, 2024$2.36B
    Mar 31, 2024$1.38$1.34$1.26 - $1.38+2.99%Beat+5.3%100 up, 2 downMay 2, 2024$2.19B
    Dec 31, 2023$1.24$1.32$1.21 - $1.35-6.06%Miss+7.8%102 up, 0 downFeb 13, 2024$2.21B
    Sep 30, 2023$1.36$1.36$1.33 - $1.410.00%In line+12.4%90 up, 1 downNov 2, 2023$2.15B
    Jun 30, 2023$1.41$1.31$1.26 - $1.36+7.63%Beat+17.5%112 up, 0 downAug 8, 2023$2.18B
    Mar 31, 2023$1.31$1.25$1.18 - $1.31+4.80%Beat-0.8%100 up, 0 downMay 4, 2023$2.00B
    Dec 31, 2022$1.15$1.15$0.01 - $1.180.00%In line+15.0%113 up, 0 downFeb 14, 2023$2.04B
    Sep 30, 2022$1.21$1.24$1.16 - $1.31-2.42%Miss-3.2%120 up, 3 downNov 3, 2022$2.00B
    Jun 30, 2022$1.20$1.22N/A-1.64%Miss+0.8%N/A1 up, 1 downAug 4, 2022$2.05B
    Mar 31, 2022$1.32$1.22$1.11 - $1.30+8.20%Beat+4.8%111 up, 1 downMay 5, 2022$1.99B
    Dec 31, 2021$1.00$0.96$0.91 - $1.00+4.17%Beat+9.9%130 up, 0 downFeb 15, 2022$1.97B
    Sep 30, 2021$1.25$1.11$1.00 - $1.19+12.61%Beat+13.6%13N/ANov 4, 2021$1.99B
    Jun 30, 2021$1.19$1.09$1.02 - $1.17+9.17%Beat+33.7%15N/AAug 5, 2021$1.95B
    Mar 31, 2021$1.26$1.04$0.96 - $1.10+21.15%Beat+32.6%15N/AMay 6, 2021$1.87B
    Dec 31, 2020$0.91$0.87$0.84 - $0.90+4.60%Beat-1.1%16N/AFeb 16, 2021$1.81B
    Sep 30, 2020$1.10$0.92$0.83 - $1.00+19.57%Beat+17.0%17N/ANov 5, 2020$1.79B
    Jun 30, 2020$0.89$0.65$0.44 - $0.74+36.92%Beat-1.1%16N/AAug 6, 2020$1.55B
    Mar 31, 2020$0.95$0.87$0.73 - $0.94+9.20%Beat+8.0%15N/AMay 6, 2020$1.53B
    Dec 31, 2019$0.92$0.88$0.84 - $0.89+4.55%Beat+16.5%14N/AFeb 13, 2020$1.67B
    Sep 30, 2019$0.94$0.89$0.78 - $0.92+5.62%Beat+13.3%14N/ANov 7, 2019$1.58B
    Jun 30, 2019$0.90$0.82$0.73 - $0.86+9.76%Beat+16.9%14N/AAug 6, 2019$1.55B
    Mar 31, 2019$0.88$0.79$0.75 - $0.84+11.39%Beat+17.3%13N/AMay 2, 2019$1.46B
    Dec 31, 2018$0.79$0.77$0.73 - $0.81+2.60%Beat+14.5%12N/AFeb 14, 2019$1.56B
    Sep 30, 2018$0.83$0.77$0.73 - $0.85+7.79%Beat+27.7%13N/ANov 1, 2018$1.48B
    Jun 30, 2018$0.77$0.70$0.65 - $0.74+10.00%Beat+45.3%15N/AAug 2, 2018$1.42B
    Mar 31, 2018$0.75$0.69$0.65 - $0.74+8.70%Beat+41.5%17N/AMay 2, 2018$1.37B
    Dec 31, 2017$0.69$0.66$0.63 - $0.69+4.55%Beat+46.8%17N/AFeb 15, 2018$1.46B
    Sep 30, 2017$0.65$0.62$0.57 - $0.66+4.84%Beat+25.0%17N/ANov 2, 2017$1.35B
    Jun 30, 2017$0.53$0.53$0.49 - $0.590.00%In line+8.2%17N/AAug 8, 2017$1.27B
    Mar 31, 2017$0.53$0.48N/A+10.42%Beat+10.4%N/AN/AMay 4, 2017$1.23B
    Dec 31, 2016$0.47$0.45N/A+4.44%Beat+9.3%N/AN/AFeb 16, 2017$1.28B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $6.42, up 8.4% from the year before. It was $1.96 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$6.42+8.4%
    Dec 31, 2024$5.92+11.3%
    Dec 31, 2023$5.32+9.0%
    Dec 31, 2022$4.88+3.8%
    Dec 31, 2021$4.70+22.1%
    Dec 31, 2020$3.85+5.8%
    Dec 31, 2019$3.64+15.9%
    Dec 31, 2018$3.14+30.8%
    Dec 31, 2017$2.40+22.4%
    Dec 31, 2016$1.96N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,800 words across 14 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,83214
    2026Q2Jun 30, 20268,85311
    2026Q1Mar 31, 20269,24114
    2025Q4Dec 31, 20259,81815
    2025Q3Sep 30, 20256,7809
    2025Q2Jun 30, 20258,04614
    2025Q1Mar 31, 20258,71213
    2024Q4Dec 31, 20248,97914

    2026Q3 Earnings Call

    Opening remarks

    Mathieu Aussermeier Senior Vice President, Corporate Finance Thank you, operator. Good morning, everyone, and welcome to the Zoetis third quarter 2026 earnings call. I am joined today by Kristin Peck, Chief Executive Officer, and Jay Saccaro, Chief Financial Officer and Chief Operating Officer. This morning, we issued a press release announcing our third quarter 2026 financial results. Before we begin, I would like to remind you that the release and corresponding earnings presentation, which we will reference during this call, are available on the Investor Relations section of our website, and that many of our statements today may be considered forward-looking statements and that actual results could differ materially from those projections. For a list and description of certain factors that could cause results to differ, I refer you to the forward-looking statements in today's press release and in our company's Exchange Act reports filed with the SEC. Additionally, today's remarks will include certain non-GAAP financial measures. Reconciliation of these non-GAAP financial measures to the most directly comparable U.S. GAAP measures can be found in our earnings press release and our company's 8-K filing dated today, November 5th, 2026. We will also reference reported and organic operational growth. Organic operational growth excludes the effect of foreign currency, as well as acquisitions and divestitures, which individually impact Zoetis' growth by 1% or more. Unless otherwise stated, all revenue growth performance metrics will be based on organic operational performance. With that, I will turn the call over to Kristin. Kristin?

    Kristin Peck CEO Thank you, Mathieu. Good morning, everyone, and thank you for joining us. Today, we reported our third quarter results with revenue and adjusted net income both declining in line with our expectations. Our diversified portfolio provided some resilience, and we focused on defending leadership positions with investments in key franchises. At the same time, we continued advancing the portfolio and innovation pipeline. While challenging dynamics are continuing, we are seeing progress in the actions we are taking and have narrowed our full-year revenue guidance to the high end of our range. As I walk you through our performance, I want to put the industry and company results in perspective and outline how we are positioning Zoetis for the near and long term. But first, I am pleased to welcome Jay to his first earnings call with Zoetis. He brings a strong track record and a valuable combination of financial and operating experience, and we're excited to have him on the team. With that, let me start with what we see across the industry. As you all know, animal health remains a long-term secular growth industry, driven by a growing global population looking to eat more protein and adopt and care for more pets.

    Frequently Asked Questions About ZTS

    When is Zoetis's next earnings date?

    Zoetis's next earnings report is expected for Feb 10, 2027.

    Did ZTS beat earnings estimates last quarter?

    Yes. Zoetis reported EPS of $1.75 for the quarter ended Sep 30, 2026, above the $1.51 estimate, a 15.89% surprise.

    What EPS do analysts expect from ZTS next quarter?

    The consensus EPS estimate for Zoetis for the quarter ending Dec 31, 2026 is $1.20 from 15 analysts, with estimates from $1.12 to $1.35.

    How often does ZTS beat earnings estimates?

    Zoetis beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +5.07%.